SG11201908865WA - Apparatus and method for absolute quantification of biomarkers for solid tumor diagnosis - Google Patents

Apparatus and method for absolute quantification of biomarkers for solid tumor diagnosis

Info

Publication number
SG11201908865WA
SG11201908865WA SG11201908865WA SG11201908865WA SG 11201908865W A SG11201908865W A SG 11201908865WA SG 11201908865W A SG11201908865W A SG 11201908865WA SG 11201908865W A SG11201908865W A SG 11201908865WA
Authority
SG
Singapore
Prior art keywords
sample
international
marker
go1n
pct
Prior art date
Application number
Other languages
English (en)
Inventor
Jiandi Zhang
Original Assignee
Quanticision Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quanticision Diagnostics Inc filed Critical Quanticision Diagnostics Inc
Publication of SG11201908865WA publication Critical patent/SG11201908865WA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201908865W 2017-06-29 2018-06-28 Apparatus and method for absolute quantification of biomarkers for solid tumor diagnosis SG11201908865WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762526425P 2017-06-29 2017-06-29
PCT/US2018/040075 WO2019006156A1 (en) 2017-06-29 2018-06-28 APPARATUS AND METHOD FOR ABSOLUTE QUANTIFICATION OF BIOMARKERS FOR SOLID TUMOR DIAGNOSIS

Publications (1)

Publication Number Publication Date
SG11201908865WA true SG11201908865WA (en) 2019-10-30

Family

ID=64734814

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201908865W SG11201908865WA (en) 2017-06-29 2018-06-28 Apparatus and method for absolute quantification of biomarkers for solid tumor diagnosis

Country Status (8)

Country Link
US (2) US10788484B2 (enExample)
EP (1) EP3646328A4 (enExample)
JP (1) JP7194128B2 (enExample)
KR (1) KR102502745B1 (enExample)
CN (1) CN110753845B (enExample)
CA (1) CA3101968A1 (enExample)
SG (1) SG11201908865WA (enExample)
WO (1) WO2019006156A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX357763B (es) 2013-10-18 2018-07-23 Univ Health Network Tratamiento para cancer pancreatico.
SG11201808629UA (en) * 2016-04-21 2018-11-29 Immatics Biotechnologies Gmbh Immunotherapy against melanoma and other cancers
DE102016209871A1 (de) 2016-06-06 2017-12-07 Robert Bosch Gmbh Stanzvorrichtung und Verfahren zum Stanzen eines Lumens und Implantieren einer Implantateinrichtung
DE102018201030B4 (de) * 2018-01-24 2025-10-16 Kardion Gmbh Magnetkuppelelement mit magnetischer Lagerungsfunktion
DE102018206750A1 (de) 2018-05-02 2019-11-07 Kardion Gmbh Vorrichtung zur induktiven Energieübertragung in einen menschlichen Körper und deren Verwendung
DE102018206754A1 (de) 2018-05-02 2019-11-07 Kardion Gmbh Verfahren und Vorrichtung zur Bestimmung der Temperatur an einer Oberfläche sowie Verwendung des Verfahrens
DE102018206725A1 (de) 2018-05-02 2019-11-07 Kardion Gmbh Empfangseinheit, Sendeeinheit, Energieübertragungssystem und Verfahren zur drahtlosen Energieübertragung
DE102018206727A1 (de) 2018-05-02 2019-11-07 Kardion Gmbh Energieübertragungssystem und Empfangseinheit zur drahtlosen transkutanen Energieübertragung
DE102018206724A1 (de) 2018-05-02 2019-11-07 Kardion Gmbh Energieübertragungssystem und Verfahren zur drahtlosen Energieübertragung
DE102018206731A1 (de) 2018-05-02 2019-11-07 Kardion Gmbh Vorrichtung zur induktiven Energieübertragung in einen menschlichen Körper und Verwendung der Vorrichtung
DE102018207611A1 (de) 2018-05-16 2019-11-21 Kardion Gmbh Rotorlagerungssystem
DE102018207575A1 (de) 2018-05-16 2019-11-21 Kardion Gmbh Magnetische Stirndreh-Kupplung zur Übertragung von Drehmomenten
DE102018208539A1 (de) 2018-05-30 2019-12-05 Kardion Gmbh Motorgehäusemodul zum Abdichten eines Motorraums eines Motors eines Herzunterstützungssystems und Herzunterstützungssystem und Verfahren zum Montieren eines Herzunterstützungssystems
DE102018208538A1 (de) 2018-05-30 2019-12-05 Kardion Gmbh Intravasale Blutpumpe und Verfahren zur Herstellung von elektrischen Leiterbahnen
DE102018208541A1 (de) 2018-05-30 2019-12-05 Kardion Gmbh Axialpumpe für ein Herzunterstützungssystem und Verfahren zum Herstellen einer Axialpumpe für ein Herzunterstützungssystem
DE102018208549A1 (de) 2018-05-30 2019-12-05 Kardion Gmbh Elektronikmodul für ein Herzunterstützungssystem und Verfahren zum Herstellen eines Elektronikmoduls für ein Herzunterstützungssystem
DE102018208550A1 (de) 2018-05-30 2019-12-05 Kardion Gmbh Leitungsvorrichtung zum Leiten eines Blutstroms für ein Herzunterstützungssystem, Herzunterstützungssystem und Verfahren zum Herstellen einer Leitungsvorrichtung
DE102018208555A1 (de) 2018-05-30 2019-12-05 Kardion Gmbh Vorrichtung zum Verankern eines Herzunterstützungssystems in einem Blutgefäß, Verfahren zum Betreiben und Herstellverfahren zum Herstellen einer Vorrichtung und Herzunterstützungssystem
DE102018210076A1 (de) 2018-06-21 2019-12-24 Kardion Gmbh Verfahren und Vorrichtung zum Erkennen eines Verschleißzustands eines Herzunterstützungssystems, Verfahren und Vorrichtung zum Betreiben eines Herzunterstützungssystems und Herzunterstützungssystem
DE102018210058A1 (de) 2018-06-21 2019-12-24 Kardion Gmbh Statorschaufelvorrichtung zur Strömungsführung eines aus einer Austrittsöffnung eines Herzunterstützungssystems ausströmenden Fluids, Herzunterstützungssystem mit Statorschaufelvorrichtung, Verfahren zum Betreiben einer Statorschaufelvorrichtung und Herstellverfahren
EP3818496A4 (en) * 2018-07-02 2022-04-20 Tempus Labs, Inc. 3D RADIOMICS PLATFORM FOR IMAGING BIOMARKER DEVELOPMENT
DE102018211297A1 (de) 2018-07-09 2020-01-09 Kardion Gmbh Herzunterstützungssystem und Verfahren zur Überwachung der Integrität einer Haltestruktur eines Herzunterstützungssystems
DE102018211327A1 (de) 2018-07-10 2020-01-16 Kardion Gmbh Laufrad für ein implantierbares, vaskuläres Unterstützungssystem
DE102018211328A1 (de) 2018-07-10 2020-01-16 Kardion Gmbh Laufradgehäuse für ein implantierbares, vaskuläres Unterstützungssystem
DE102018212153A1 (de) 2018-07-20 2020-01-23 Kardion Gmbh Zulaufleitung für eine Pumpeneinheit eines Herzunterstützungssystems, Herzunterstützungssystem und Verfahren zum Herstellen einer Zulaufleitung für eine Pumpeneinheit eines Herzunterstützungssystems
AU2019320533B2 (en) 2018-08-07 2024-11-21 Kardion Gmbh Bearing device for a cardiac support system, and method for flushing an intermediate space in a bearing device for a cardiac support system
CN114631027A (zh) * 2019-11-01 2022-06-14 烟台康体诊医疗科技有限公司 基于定量生物标志物的癌症诊断方法及其数据库
AU2021207312A1 (en) * 2020-01-17 2022-06-30 Universität Zürich Single cell pathology analysis of tumour samples
DE102020102474A1 (de) 2020-01-31 2021-08-05 Kardion Gmbh Pumpe zum Fördern eines Fluids und Verfahren zum Herstellen einer Pumpe
US11699551B2 (en) 2020-11-05 2023-07-11 Kardion Gmbh Device for inductive energy transmission in a human body and use of the device

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003252235A1 (en) * 2002-07-25 2004-02-16 Ajinomoto Co., Inc. Method of analyzing protein
DE60200248T2 (de) * 2002-08-01 2005-01-27 Mtm Laboratories Ag Verfahren für Lösung-basierte Diagnose
DE102005023011A1 (de) * 2005-05-19 2006-11-23 Qiagen Gmbh Quantitative Proteinbestimmung von Formalin fixiertem Gewebe
CA2653398A1 (en) * 2006-05-26 2007-12-06 Board Of Regents, The University Of Texas System Reverse phase protein array, protein activation and expression signatures, and associated methods
GB0611669D0 (en) * 2006-06-13 2006-07-19 Astrazeneca Uk Ltd Mass spectrometry biomarker assay
JPWO2008075664A1 (ja) * 2006-12-21 2010-04-15 味の素株式会社 癌の評価方法、ならびに癌評価装置、癌評価方法、癌評価システム、癌評価プログラムおよび記録媒体
US8771962B2 (en) * 2008-10-02 2014-07-08 Sarka O. Southern Health test for a broad spectrum of health problems
EP2239675A1 (en) 2009-04-07 2010-10-13 BIOCRATES Life Sciences AG Method for in vitro diagnosing a complex disease
JP2013099253A (ja) * 2010-03-11 2013-05-23 Intec Systems Institute Inc 肺癌または子宮頸癌の診断マーカー
PT2714926E (pt) * 2011-05-25 2015-11-03 Novartis Ag Biomarcadores para o cancro do pulmão
US8293487B1 (en) * 2012-01-06 2012-10-23 Jiandi Zhang Zestern, a simple, fast, specific and quantifiable improvement of immunodetection process
WO2016172216A1 (en) * 2015-04-20 2016-10-27 The Methodist Hospital Use of soluble crkl compositions as breast cancer biomarkers and predictors of cancer metastasis
US9933418B2 (en) * 2015-05-26 2018-04-03 Quanticision Diagnostics Inc. Multi-unit plate for electroblotting and immunoblot analysis
IL294138A (en) * 2015-05-29 2022-08-01 Genentech Inc Therapeutic and diagnostic methods for cancer
EP3465200A4 (en) * 2016-06-05 2020-07-08 Berg LLC PATIENT STRATIFICATION SYSTEMS AND METHODS AND IDENTIFICATION OF POTENTIAL BIOMARKERS

Also Published As

Publication number Publication date
CA3101968A1 (en) 2019-01-03
KR20200020906A (ko) 2020-02-26
US20190004037A1 (en) 2019-01-03
EP3646328A4 (en) 2021-04-21
JP7194128B2 (ja) 2022-12-21
EP3646328A1 (en) 2020-05-06
US20210011010A1 (en) 2021-01-14
JP2020526747A (ja) 2020-08-31
CN110753845A (zh) 2020-02-04
WO2019006156A1 (en) 2019-01-03
US10788484B2 (en) 2020-09-29
KR102502745B1 (ko) 2023-02-23
CN110753845B (zh) 2023-08-22

Similar Documents

Publication Publication Date Title
SG11201908865WA (en) Apparatus and method for absolute quantification of biomarkers for solid tumor diagnosis
SG11201901866TA (en) Collection probe and methods for the use thereof
SG11201908767QA (en) Method for accurate diagnosis of a disease targeting biomarkers in liquid biopsy
SG11201805906WA (en) Diagnostic and prognostic methods for cardiovascular diseases and events
SG11201906247WA (en) Devices, systems, and methods for sample collection
SG11201804086VA (en) Methods and compositions for nucleic acid analysis
SG11201408383SA (en) Methods of detecting diseases or conditions using circulating diseased cells
SG11201408002TA (en) Multi-parameter diabetes risk evaluations
SG11201809294RA (en) Systems and methods for sensor data analysis through machine learning
SG11201808261RA (en) Genetic variant-phenotype analysis system and methods of use
SG11201807366WA (en) System and method for generating custom shoe insole
SG11201906844RA (en) Biometric feature database establishing method and apparatus
SG11201407668XA (en) Method and device for detecting an analyte in a body fluid
SG11201408434QA (en) Targeted rna-seq methods and materials for the diagnosis of prostate cancer
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201407803TA (en) Nmr measurements of glyca
SG11201408022XA (en) Enterprise triggered 2chk association
SG11201901991QA (en) Methods of detecting per cell pd-l1 expression and uses thereof
SG11201906413XA (en) Exposure apparatus
SG11201808475XA (en) Method and apparatus for providing a pharmacokinetic drug dosing regiment
SG11202000444PA (en) Sequencing output determination and analysis with target-associated molecules in quantification associated with biological targets
SG11201407341TA (en) Surface features mapping
SG11201804020YA (en) Assays and methods for selecting a treatment regimen for a subject with leukemia
SG11201907490XA (en) Non-human animal models of retinoschisis
SG11201907710PA (en) Method and apparatus for health prediction by analyzing body behaviour pattern